IPAD-DB ID | C00429 |
Name | Morusin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 5 H 2 4 O 6 |
Molecular Weight | 420.5g/mol |
IUPAC Name | 2-(2, 4-dihydroxyphenyl)-5-hydroxy-8, 8-dimethyl-3-(3-methylbut-2-enyl)pyrano[2, 3-h]chromen-4-one |
InChI | InChI=1S/C25H24O6/c1-13(2)5-7-17-22(29)21-19(28)12-20-16(9-10-25(3, 4)31-20)24(21)30-23(17)15-8-6-14(26)11-18(15)27/h5-6, 8-12, 26-28H, 7H2, 1-4H3 |
InChIKey | XFFOMNJIDRDDLQ-UHFFFAOYSA-N |
Canonical SMILES | CC(=CCC1=C(OC2=C(C1=O)C(=CC3=C2C=CC(O3)(C)C)O)C4=C(C=C(C=C4)O)O)C |
PubChem CID | 5281671 |
DrugBank Accession Number | - |
CAS Registry Number | 62596-29-6 |
Molecular Weight(Computed by SwissADME) | 420.45 |
Hac(Computed by SwissADME) | 31 |
Volume(Computed by ADMETlab 2.0) | 433.107 |
Density(Computed by ADMETlab 2.0) | 0.97 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 6 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 24 |
Flexibility(Computed by ADMETlab 2.0) | 0.125 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.713 |
LogD(Computed by ADMETlab 2.0) | 4.02 |
logP(Computed by ADMETlab 2.0) | 5.27 |
TPSA(Computed by SwissADME) | 100.13 Ų |
Hbond Acceptor(Computed by SwissADME) | 6 |
Hbond Donor(Computed by SwissADME) | 3 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.95 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | No, 1 violation: XLOGP3>5 |
Bioavailability Score(Computed by SwissADME) | 0.55 |